Primaire tabs
Exporteer 74 resultaten:
Filters: Auteur is L. Tesolin
The change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine, Q&A,
, OMCL annual meeting 2022, 16/06/2022, EDQM, strasbourg, (2022)
Concept paper on the change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine,
, 06/04/2022, Strasbourg, France, p.5, (2022)
The consistency approach for the substitution of in vivo testing for the quality control of established vaccines: practical considerations and progressive vision,
, Open Research Europe, 13/12/2022, (2022)
Manufacture and control of vaccine adjuvants from OMCL perspective,
, Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
OCABR guideline for inactivated COVID-19 vaccines,
, 16/11/2022, EDQM, strasbourg, p.12, (2022)
Training on biological methods (Immunology),
, 13/10/2022, Sciensano, Bruxelles, (2022)
The vaccine Batch release procedure in Europe,
, Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
"WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines",
, "WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines", 08/11/2022, Mascate, Oman sultanate, (2022)
Workshop on implementation of single dilution assay for in vivo testing,
, Workshop on implementation of single dilution assay for in vivo testing, 22/11/2022, Brussels, Belgium, (2022)
The batch release procedure in Europe ; Bacterial and polysaccharide vaccines,
, ULB dept Pharmacy, (2021)
The batch release procedure in Europe; manufacture and control of vaccine adjuvants; bacterial and polysaccharide vaccines,
, ULB dept Pharmacy, (2021)
Evaluation of OCBAR testing of recombinant vaccine at bulk monovalent stage,
, OMCL annual meeting, (2021)
Guideline for Pandemic COVID-19 Vaccine (mRNA),
, 01/05/2021, EDQM, strasbourg, p.16, (2021)
Guideline for Pandemic COVID-19 Vaccine (Non-replicating Adenovirus-vectored vaccine),
, 01/04/2021, EDQM, strasbourg, p.13, (2021)
Guideline for Pandemic COVID-19 Vaccine (Recombinant Spike Protein),
, EDQM, strasbourg, p.17, (2021)
How to implement trend analysis,
, Training Saudi Food and Drug Authority, (2021)
Libération des lots de vaccins,
, Training Senegal Agency, (2021)
Panel discussion official forum Taiwan FDA to share/discuss about COVID-19 vaccine testing, medicines quality issues, and batch release procedures,
, Taiwan FDA to share/discuss about COVID-19 vaccine testing, medicines quality issues, and batch release procedures , 26/10/2021, Taiwan, (2021)
Roadmap from the classical control strategy of vaccines to the consistency testing based control strategy,
, VAC2VAC Workshop 24 June 2021, (2021)
RSV vaccine GSK : OCABR testing,
, EDQM OCABR drafting group, 19/10/2021, EDQM, Strasbourg, (2021)
Biological reference standards for multivalent vaccines: qualification strategies and challenges from a national control lab perspective,
, CASS Bioassays 2020, Gaithersburg PA, USA, 27/04/2022, Gaithersburg, PA, USA, (2020)
Concept paper : rationale for deletion of the O-acetyl test on meningoccocal vaccines guidelines,
, (2020)
Establishment of single dilution assays for animal based potency determinations,
, WHO Webinar: Establishment of a single dilution potency assay, (2020)
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mindset of the manufacturer.,
, EDQM & European Pharmacopoeia: State-of-the-Art Science for Tomorrow’s Medicines, 19-20 May 2019, Issue EDQM, (2019)